CAS 782500-75-8

Albiglutide

Description:

Albiglutide is a synthetic peptide and a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily used in the management of type 2 diabetes mellitus. It is designed to enhance glucose-dependent insulin secretion, suppress glucagon release, and slow gastric emptying, thereby aiding in blood glucose control. Albiglutide is characterized by its extended half-life, which allows for once-weekly administration, making it convenient for patients. The substance is a fusion protein composed of a modified GLP-1 molecule linked to a human albumin, which contributes to its stability and prolonged action in the bloodstream. Albiglutide is typically administered via subcutaneous injection and is known to have a favorable safety profile, with common side effects including gastrointestinal disturbances. Its mechanism of action not only helps in glycemic control but also promotes weight loss, which is beneficial for many patients with type 2 diabetes. However, it is essential for patients to consult healthcare professionals for personalized advice and monitoring while using this medication.

Formula: C₃₂₃₂H₅₀₃₂N₈₆₄O₉₇₉S₄₁

Synonyms:

• Naliglutide
• Albugon

Albiglutide

CAS: 782500-75-8

Formula: C₁₄₈H₂₂₄N₄₀O₄₅

Purity: 95%

Molecular weight: 3283.6032

Ref: IN-DA00G4BF

Albiglutide Fragment

CAS: 782500-75-8

Albiglutide fragment is a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36).

Formula: C₁₄₈H₂₂₄N₄₀O₄₅

Purity: 98%

Color and Shape: Solid

Molecular weight: 3283.6

Ref: TM-TQ0004

Albiglutide

CAS: 782500-75-8

Formula: C₁₄₈H₂₂₄N₄₀O₄₅

Molecular weight: 3283.66

Ref: 4Z-PA-366001

H-HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2

CAS: 782500-75-8

H-HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 is a custom research peptide; min purity 95%, TFA salt. For different specs please use the Peptide Quote Tool

Formula: C₁₄₈H₂₂₃N₃₉O₄₆

Molecular weight: 3,284.63 g/mol

Ref: 3D-PH00228

Albiglutide Fragment

CAS: 782500-75-8

Albiglutide Fragment is a fragment of the soybean trypsin inhibitor, which is a protein that has been found to inhibit the activity of pancreatic enzymes. The fragment was designed to be used in diagnosis and treatment of infectious diseases. Albiglutide Fragment binds to the glucagon-like peptide (GLP) receptors on cells in the intestine and pancreas, inhibiting the production of pro-inflammatory cytokines and reducing inflammation. When it is bound to GLP receptors, albiglutide fragment blocks cell signals that lead to diabetes, obesity, and metabolic syndrome. Albiglutide Fragment can also be used as a contrast agent for imaging techniques such as magnetic resonance imaging or ultrasound. It binds to cells in high concentrations and can help visualize profiles of these cells.

Formula: C₁₄₈H₂₂₄N₄₀O₄₅

Purity: Min. 95%

Molecular weight: 3,283.6 g/mol

Ref: 3D-HGB50075